Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The use of fondaparinux in preventing thromboembolism in high risk trauma patients

Trial Profile

The use of fondaparinux in preventing thromboembolism in high risk trauma patients

Completed
Phase of Trial: Phase II/III

Latest Information Update: 23 Dec 2013

At a glance

  • Drugs Fondaparinux sodium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Oct 2008 Actual patient number (106) added as reported by ClinicalTrials.gov.
    • 05 Oct 2008 Status changed from recruiting to completed as reported by CT.gov
    • 05 Oct 2008 Actual end date (June 2008) added as reported by CT.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top